MENU
COCP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cocrystal Pharma (COCP) Ownership - Who owns Cocrystal Pharma?

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses... Show more

Profile

Industry
Pharmaceuticals Generic
Address
19805 North Creek Parkway
Phone
+1 877 262-7123
Employees
12
Web
https://www.cocrystalpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.87M
P/E Ratio
N/A
Total Cash
6.92M
Projected Growth
N/A
Total Debt
1.73M
Revenue
N/A
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash/Share
0.68
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

COCP
Capitalization
15.9M
P/E Ratio
N/A
Risk (Beta)
1.70
Dividend Yield
N/A
Total Cash
6.92M
Total Cash/Share
0.68
Total Debt
1.73M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.3M
P/B Ratio
2.08
Cash Flow
N/A
Earnings
-1.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
4.57
Current Revenue Per Employee
39230.77
Dividends Per Share - Security
N/A
EBITDA
-15.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.18
Revenue To Assets
-85.20
Shares Held By Institutions
1.55M
Shares Outstanding - Current
10.2M
Total Liabilities
3.36M
Total Volume MTD
N/A
Value
-1
Gain YTD
-26.238
View a ticker or compare two or three
COCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel medicines for use in the treatment of human viral diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
19805 North Creek Parkway
Phone
+1 877 262-7123
Employees
12
Web
https://www.cocrystalpharma.com